Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients.

被引：0
|
作者：
Bernstein, DE
Khan, R
Jeffers, LJ
Reddy, KR
Schiff, ER
机构：
[1] Winthrop Univ Hosp, Mineola, NY 11501 USA
[2] Univ Miami, VA Med Ctr, Miami Beach, FL USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2159
引用
收藏
页码：702A / 702A
页数：1
相关论文
共 50 条
  • [1] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients
    Bernstein, DE
    Jeffers, LJ
    Lake-Bakaar, G
    Reddy, KR
    Schiff, ER
    GASTROENTEROLOGY, 1999, 116 (04) : A1190 - A1190
  • [2] EFFECTS OF CASCADE FILTRATION IN COMBINATION WITH INTERFERON AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDER CHRONIC HEPATITIS C PATIENTS
    Ramunni, A.
    Brescia, P.
    Burzo, M.
    Verno, L.
    Rendina, M.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 436 - 436
  • [3] Combination treatment with interferon (IFN) and ribavirin (RBV) for hepatitis C (HCV) in HIV co-infection patients.
    Dieterich, DT
    Weisz, KB
    Goldman, DJ
    Malicdem, ML
    HEPATOLOGY, 1999, 30 (04) : 266A - 266A
  • [4] Retreatment of IFN/ribavirin non-responder hepatitis C patients: Benefit of PEG-interferon/ribavirin amantadine.
    Maynard, M
    Ahmed, SNS
    Bailly, F
    Rozier, F
    Benmakhlouf, N
    Bourne-Branchu, V
    Fazly, T
    Nemoz, C
    Adeleine, P
    Pradat, P
    Trepo, C
    HEPATOLOGY, 2004, 40 (04) : 398A - 398A
  • [5] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Oguz, Dilek
    Cicek, Bahattin
    Filik, Levent
    Odemis, Bulent
    Kilic, Mesut
    Altintas, Engin
    Zengin, Neslihan
    Altiparmak, Emin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (04) : 580 - 583
  • [6] Treatment of interferon non-responder patients with chronic hepatitis C in Asia
    Nishioka, M.
    CHRONIC HEPATITIS: METABOLIC, CHOLESTATIC, VIRAL AND AUTOIMMUNE, 2007, 157 : 110 - 118
  • [7] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Dilek Oguz
    Bahattin Cicek
    Levent Filik
    Bulent Odemis
    Mesut Kilic
    Engin Altintas
    Neslihan Zengin
    Emin Altiparmak
    World Journal of Gastroenterology, 2005, (04) : 580 - 583
  • [8] Early prediction of sustained viral responder and non-responder during interferon and ribavirin combination therapy in chronic hepatitis C
    Nakamura, H
    HEPATOLOGY RESEARCH, 2005, 33 (04) : 269 - 271
  • [9] Daily use of ribavirin-interferon combination in earlier non-responder or relapser patients with chronic hepatitis C.
    Karasu, Z
    Gurakar, A
    Jazzar, A
    McMillon, G
    Hulagu, S
    Wright, H
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [10] Treatment of hepatitis C (HCV) infection in patients with bleeding disorders using an interferon (IFN)/ribavirin (RBV) combination.
    Shields, PL
    Mutimer, DJ
    Roberts, A
    Britnell, T
    Wilde, JT
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 84 - 84
12345